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UTILITY OF LIVER BIOPSY IN HIV-INFECTED PATIENTS PRESENTING WITH
FEBRILE ILLNESSES AND INCONCLUSIVE EVALUATION
J. SHAVADIA, S. MWANZI, F. RANA and M. TWAHIR
ABSTRACT
Objectives: To determine the utility of liver biopsy in providing a diagnosis in HIVinfected patients presenting with febrile illnesses and inconclusive initial investigative
work up.
Design: A retrospective descriptive study.
Setting: The Aga Khan University Hospital, Nairobi.
Subjects: Twelve in-patients with HIV disease who underwent liver biopsy following
inconclusive initial investigative work up for febrile illnesses between January and
December 2007.
Results: Seven out of 12 patients had granulomatous hepatitis reported on histology
with characteristic tuberculous epitheloid granulomas all having stainable acid-alcohol
fast bacilli on Ziehl-Nielsen (ZN) stain. The mean alkaline phosphatase (ALP) and
gamma glutamyl transpeptidase (GGT) levels in these seven patients were 260U/L and
304U/L respectively, while the mean aspartate aminotransferase (SGOT) and alanine
aminotransferase (SGPT) were 106U/L and 72U/L respectively.
Conclusion: Disseminated tuberculosis is still among the most common causes of
unexplained pyrexia in our HIV- infected cohort and a liver biopsy, performed earlier
in the investigative work up of unexplained fever in the HIV-infected patient, would
be a useful adjunct in providing a diagnosis.

INTRODUCTION
Physicians taking care of patients with Human
Immunodeﬁciency Virus (HIV) infection routinely
come across patients presenting with febrile illnesses
and are posed not only with the challenge of making an
appropriate diagnosis but initiating evidence-based
therapy especially when the initial ‘septic-screen’ is
reported normal.
With differential diagnosis ranging from
infections to malignancies to less common connective
tissue disorders among others, most patients undergo
ﬁrst line investigations including a full blood count,
malaria slides, sputum microscopy and culture,
urinalysis, chest radiographs and blood cultures
since the commoner cause of a febrile illness in HIV
infected patients in our settings is infective. If these
non-invasive investigations are non conclusive,
patients are then subjected to lymph node biopsies

(if present and accessible), bone marrow aspirate
(BMA) and cultures and a liver biopsy.
In clinical practice, due to the endemicity of
tuberculosis in the HIV infected population, the
atypically bland manner of its presentation, and the
signiﬁcant morbidity, mortality and public health
concern associated with untreated tuberculosis, most
patients would be initiated on an empirical ‘trial of
anti- tuberculous therapy’ if the initial septic screen
is reported normal.
Autopsy studies done in Kenya on HIV infected
adults found previously undiagnosed tuberculosis
present in 50% of the cases, 80% of whom had
disseminated disease. In over half of the patients who
had disseminated disease, tuberculous granulomas
were evident in the liver (1).
We therefore decided to evaluate the role of a
liver biopsy in HIV infected patients presenting with
a febrile illness and having an inconclusive diagnostic
work up.

EAST AFRICAN MEDICAL JOURNAL

506

MATERIALS AND METHODS
A retrospective study performed between January and
December 2007 at The Aga Khan University Hospital,
Nairobi, where twelve HIV infected patients who
presented with a febrile illness for a mean duration
of 2.1 weeks, underwent the following investigations
as part of the initial septic screen:
(i) Full blood count and malaria slides.
(ii) Sputum (induced with 3% saline, if cough was
non productive) for microscopy and a Ziehl
Nielsen stain.
(iii) Urine and blood cultures obtained prior to
initiation of empirical antibiotics.
(iv) Chest radiograph.
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Patients, who had inconclusive initial septic screen,
underwent a repeat physical examination looking
particularly for evidence of lymphadenopathy.
Patients who did not have enlarged lymph nodes
or declined consent for excision underwent a bone
marrow aspirate (BMA) followed by a diagnostic liver
biopsy if the BMA cytology was inconclusive.
Baseline characteristics: The median age of the cohort
was 40 years (range 32-47years) and sex ratio
distributed as M:F = 1:2. The baseline characteristics of
all twelve patients are shown in Table 1. The pertinent
liver function tests are illustrated in Table 2.

Table 1
Baseline characteristics
Age
41
40
43
33
43
40
39
47
35
30
32
42
Age
Sex
WBC
LYM
CXR
NA

Sex
M
F
M
F
M
F
F
M
F
F
F
F
=
=
=
=
=
=

WBC
6.5
6.4
6.7
5.9
2.9
2.2
4.2
5.9
7.2
5.7
1.6
6.3

LYM
6%
13%
22%
43%
41%
31%
54%
9%
4%
10%
9%
20%

Expressed in years
M – male F – female
White cell count
Lymphocyte
Chest X-ray
Not available

ESR
50
72
43
38
47
15
36
30
70
64
68
65

CXR
URINE C/S
N
NG
N
NG
NON SP INF
NG
N
NG
N
NG
N
NG
N
NG
N
NG
N
NG
N
NG
N
NG
N
NG

URINE C/S
BLOOD C/S
CD4
ESR
NON SP INF
NG

=
=
=
=
=
=

BLOOD C/S
NG
NG
NG
NA
NG
NG
NG
NG
NG
NG
NG
NG

CD4
42
NA
215
NA
28
13
NA
490
50
13
314
73

Urine culture and sensitivity
Blood culture and sensitivity
CD4 count (cells/mm3)
Erythrocyte sedimentation rate
Non speciﬁc infective process
No growth

Table 2
Liver function tests
ALP
GGT
99
124
202
131
238
696
814
371
182
148
192
471
52
29
68
351
221
345
216
417
98
86
151
352
ALP = Alkaline phosphatase (U/L)
SGOT = Aspartate aminotransferase (U/L)

SGOT
SGPT
107
58
63
47
121
108
56
64
40
40
63
41
33
10
93
53
307
226
80
62
40
18
45
70
GGT = Gamma glutamyl transpeptidase (U/L)
SGPT = Alanine aminotransferase (U/L)
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RESULTS

DISCUSSION

Majority of the patients in the study (83%) had an
absolute lymphopenia (<1.5x109/L) with a mean
lymphocyte count of 1.01 x 109/L (0.14 – 2.54 x 109/L).
This was reﬂected in the mean CD4 count of 137cells/
mm3 (13 – 490 cell/mm3). The mean ESR for our study
patients was 50mm/hour (15 – 72mm/hour).
All patients, who had blood and urine cultures
drawn prior to initiation of empirical antibiotic
therapy, had no growth at 48 hours. All chest
radiographs were reported as normal, except one
who had a non speciﬁc infective pneumonitis. The
mean alkaline phopshatase (ALP) and gamma
glutamyl transpeptidase (GGT) of the cohort was
211U/L and 293U/L respectively. Liver transaminases
were elevated in 75% of the patients with the mean
aspartate aminotransferase (SGOT) at 67U/L and
alanine aminotransferase (SGPT) at 64U/L.
All but one patient had either no evidence or
non- accessible lymphadenopathy. The one patient
had anterior cervical lymphadenopathy but declined
consent for an excisional lymph node biopsy. On
evaluation of the bone marrow aspirates, no patient
had cytological evidence of lymphoma. One patient
had M. tuberculosis while another had mycobacteria
other than tuberculosis (MOTT) grown on bone
marrow culture at ﬁve weeks.
All twelve patients underwent a liver biopsy
since the BMA was inconclusive while bone marrow
culture reports were awaited. Seven out of the 12
biopsies showed features of tuberculous hepatitis
with preservation of the liver architecture. Five of
the seven showed well deﬁned classical necrotising
granulomas with epithelioid cells and the remaining
two showed ill deﬁned non epithelioid focal areas of
necrosis with neutrophilic inﬁltrate predominantly.
All seven biopsies had acid alcohol fast bacilli on
ZN staining, ﬁve on the initial sections and two on
deeper sections.
Of the ﬁve cases that did not show tuberculous
hepatitis, two showed steatohepatitis (one having
cirrhosis), while the rest showed chronic hepatitis of
mild activity and no ﬁbrosis on the Ishaak scoring
system (1).
On sub-analysis of the seven patients who had
granulomas on liver biopsy, the mean ALP and GGT
levels were 260U/L and 304U/L respectively, while
the mean SGOT and SGPT were 106U/L and 72U/L
respectively.
Ten patients were both hepatitis B surface
antigen (HBsAg) and hepatitis C antibody (anti
HCV antibody) negative. The HBsAg and anti HCV
antibody results of the remaining two patients
were not available. However, all patients who had
granulomatous hepatitis were HBsAg and anti HCV
negative.

Fever of unknown or uncertain origin (FUO)
constitutes a common clinical challenge in patients
infected with HIV. It becomes more frustrating after
the initial investigations fail to identify the source of
their fever, as this not only increases patient hospital
stay but also puts them through more invasive
investigative work-up. Our study results were similar
to results from Rana et al (2) who reported from the
same geographical setting, and in close approximation
to results from Nigeria where 65% of HIV infected
patients who underwent a post-mortem liver biopsy
had evidence of tuberculosis (3).
García-Ordóñez et al (4) found tuberculosis in
50% of their percutaneous liver biopsies from HIVinfected patients presenting with FUO. They also
reported leishmaniasis in 20% of their cohort. Despite
the existence of leishmaniasis endemic areas and
publications of leishmania outbreaks in Kenya (5-7),
we interestingly did not ﬁnd any case of leishmaniasis
in our HIV-infected cohort.
Other studies in developing countries have
however reported a much lower prevalence of
tuberculous hepatitis in HIV infected patients.
Amarapurkar et al (8) demonstrated a prevelance
rate of about 36% while Piratvisuth et al (9) had a
prevalence rate of 33%.
From our study cohort, patients who had
tuberculous hepatitis on biopsy had a two-fold
increase in their mean liver transaminase levels,
and a several fold increase in their ALP and GGT
levels. The results of this study, although limited by
its small numbers, demonstrate that a liver biopsy
would increase the diagnostic yield for mycobacterial
infections in patients with HIV/AIDS presenting with
a febrile illness and a non diagnostic initial work
up. This is especially so in patients who also have
derangements in their liver function tests. All patients
who had granulomatous hepatitis were treated for M.
tuberculosis, except one patient whose bone marrow
culture was positive for MOTT.
We therefore recommend that a liver biopsy
be performed earlier in the diagnostic hierarchy of
unexplained fever in HIV – infected patients, since it
leads to a change in the clinical management of such
patients.
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